These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20231582)

  • 21. Clinical inquiries. How useful is high-sensitivity CRP as a risk factor for coronary artery disease?
    Hull SK; Collins LJ; Saseen JJ
    J Fam Pract; 2005 Mar; 54(3):268, 271-2. PubMed ID: 15755382
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.
    de Winter RJ; Heyde GS; Koch KT; Fischer J; van Straalen JP; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; Piek JJ; Tijssen JG
    Eur Heart J; 2002 Jun; 23(12):960-6. PubMed ID: 12069451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [C-reactive protein and coronary artery disease].
    Acartürk E
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):203-4. PubMed ID: 15355819
    [No Abstract]   [Full Text] [Related]  

  • 27. [Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
    Henderson RA; Timmis AD
    G Ital Cardiol (Rome); 2012 Apr; 13(4):244-53. PubMed ID: 22495641
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein.
    O'Keefe JH; Cordain L; Jones PG; Abuissa H
    Am J Cardiol; 2006 Jul; 98(1):135-9. PubMed ID: 16784936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity C-reactive protein mediates in part the impact of ABO blood group on coronary artery disease.
    Gong P; Li S; Luo SH; Zhang Y; Li XL; Guo YL; Zhu CG; Xu RX; Dong Q; Liu G; Zeng RX; Li JJ
    Int J Cardiol; 2014 Dec; 177(2):641-3. PubMed ID: 25449469
    [No Abstract]   [Full Text] [Related]  

  • 31. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
    Schroecksnadel K; Grammer TB; Boehm BO; März W; Fuchs D
    Thromb Haemost; 2010 May; 103(5):926-35. PubMed ID: 20216983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein, heart disease risk, and the popular media.
    Tracy RP; Kuller LH
    Arch Intern Med; 2005 Oct; 165(18):2058-60. PubMed ID: 16216994
    [No Abstract]   [Full Text] [Related]  

  • 35. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
    Danesh J; Wheeler JG; Hirschfield GM; Eda S; Eiriksdottir G; Rumley A; Lowe GD; Pepys MB; Gudnason V
    N Engl J Med; 2004 Apr; 350(14):1387-97. PubMed ID: 15070788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NICE recommendations for the management of hyperglycaemia in acute coronary syndrome.
    Corbett SJ
    Heart; 2012 Aug; 98(16):1189-91. PubMed ID: 22735684
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease.
    Ribichini F; Taggart D
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):663-6. PubMed ID: 21555430
    [No Abstract]   [Full Text] [Related]  

  • 39. How to use C-reactive protein in acute coronary care.
    Biasucci LM; Koenig W; Mair J; Mueller C; Plebani M; Lindahl B; Rifai N; Venge P; Hamm C; Giannitsis E; Huber K; Galvani M; Tubaro M; Collinson P; Alpert JS; Hasin Y; Katus H; Jaffe AS; Thygesen K;
    Eur Heart J; 2013 Dec; 34(48):3687-90. PubMed ID: 24204013
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of NICE to resolve the question about the management of hyperglycaemia in acute coronary syndrome.
    Birkhead J; Weston C; Hammersley M
    Heart; 2012 Aug; 98(16):1192-3. PubMed ID: 22572049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.